US4692433A
(en)
*
|
1983-10-12 |
1987-09-08 |
The Regents Of The University Of California |
Method and composition for regulating serum calcium levels of mammals
|
WO1995013796A1
(en)
*
|
1993-11-16 |
1995-05-26 |
Depotech Corporation |
Vesicles with controlled release of actives
|
JPS60152410A
(en)
*
|
1984-01-23 |
1985-08-10 |
Pola Chem Ind Inc |
External preparation for skin
|
CH668554A5
(en)
*
|
1984-04-09 |
1989-01-13 |
Sandoz Ag |
LIPOSOMAS CONTAIN WHICH POLYPEPTIDES WITH INTERLEUKIN-2 ACTIVITY AND METHOD FOR THE PRODUCTION THEREOF.
|
JPS61100518A
(en)
*
|
1984-10-22 |
1986-05-19 |
Ono Pharmaceut Co Ltd |
Lyophilized ribosome pharmaceutical preparation comprising dimyristoylphosphatidylcholine as main component
|
GB8428222D0
(en)
*
|
1984-11-08 |
1984-12-19 |
Bentall R H C |
Quantifying interaction of induced currents
|
US5023087A
(en)
*
|
1986-02-10 |
1991-06-11 |
Liposome Technology, Inc. |
Efficient method for preparation of prolonged release liposome-based drug delivery system
|
US4849227A
(en)
*
|
1986-03-21 |
1989-07-18 |
Eurasiam Laboratories, Inc. |
Pharmaceutical compositions
|
ATE115403T1
(en)
*
|
1987-01-27 |
1994-12-15 |
Vestar Inc |
DOSAGE FORM CONSISTING OF PHOSPHOLIPIDS FOR WATER-INSOLUBLE ACTIVE SUBSTANCES.
|
US5723147A
(en)
*
|
1987-02-23 |
1998-03-03 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
US5811119A
(en)
*
|
1987-05-19 |
1998-09-22 |
Board Of Regents, The University Of Texas |
Formulation and use of carotenoids in treatment of cancer
|
US5811118A
(en)
*
|
1987-05-22 |
1998-09-22 |
The Liposome Company, Inc. |
Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
|
AU617678B2
(en)
*
|
1987-05-22 |
1991-12-05 |
Liposome Company, Inc., The |
Prostaglandin-lipid formulations
|
US5262168A
(en)
*
|
1987-05-22 |
1993-11-16 |
The Liposome Company, Inc. |
Prostaglandin-lipid formulations
|
US5925375A
(en)
*
|
1987-05-22 |
1999-07-20 |
The Liposome Company, Inc. |
Therapeutic use of multilamellar liposomal prostaglandin formulations
|
SE457933B
(en)
*
|
1987-07-06 |
1989-02-13 |
Larsson Kare |
PHARMACEUTICAL COMPOSITION INCLUDING A WATER DISPERSED MIXTURE OF LIPIDS, MONOGLYCERIDES AND PHOSPHATIDYLCOLINE AND ITS APPLICATION FOR THE PREPARATION OF A GASTRONIN TESTINALLY EFFECTIVE COMPOSITION
|
US5807572A
(en)
*
|
1988-02-18 |
1998-09-15 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
US5422120A
(en)
*
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
GB8822857D0
(en)
*
|
1988-09-29 |
1988-11-02 |
Patralan Ltd |
Pharmaceutical formulations
|
FR2649610B1
(en)
*
|
1989-07-13 |
1994-06-03 |
Dior Christian Parfums |
COSMETIC OR PHARMACEUTICAL AND PARTICULARLY DERMATOLOGICAL COMPOSITION CONTAINING AMPC OR ITS LIPOSOME DERIVATIVES
|
DE4005711C1
(en)
*
|
1990-02-23 |
1991-06-13 |
A. Nattermann & Cie Gmbh, 5000 Koeln, De |
|
DE4108902A1
(en)
*
|
1990-08-06 |
1992-02-13 |
Nattermann A & Cie |
Aq. liposome systems
|
US5556637A
(en)
*
|
1990-08-06 |
1996-09-17 |
A. Nattermann & Cie. Gmbh |
Water containing liposome system
|
DE4107153A1
(en)
*
|
1991-03-06 |
1992-09-10 |
Gregor Cevc |
Compsns. for application of active agents
|
DE4107152C2
(en)
*
|
1991-03-06 |
1994-03-24 |
Gregor Cevc |
Preparations for non-invasive administration of antidiabetics
|
US6165500A
(en)
*
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
FR2685868B1
(en)
*
|
1992-01-03 |
1995-06-23 |
Corbiere Jerome |
NOVEL PHARMACEUTICAL PREPARATIONS BASED ON PEPTIDES FOR THE GENERAL ROUTE.
|
WO1995001163A1
(en)
*
|
1992-01-03 |
1995-01-12 |
Corbiere Jerome |
Novel pharmaceutical peptide preparations for general delivery
|
AU3442093A
(en)
*
|
1992-01-16 |
1993-08-03 |
Argus Pharmaceuticals, Inc. |
Formulation and use of carotenoids in treatment of cancer
|
IL101241A
(en)
*
|
1992-03-16 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
|
US5989587A
(en)
*
|
1992-10-23 |
1999-11-23 |
National Research Council Of Canada |
Formation of stable liposomes from lipid extracts of archaeobacteria (archaeu)
|
JPH0657741U
(en)
*
|
1993-01-22 |
1994-08-12 |
株式会社村上開明堂 |
Mirror device with monitoring function
|
US5455044A
(en)
*
|
1993-05-14 |
1995-10-03 |
Depotech Corporation |
Method for treating neurological disorders
|
US5853755A
(en)
*
|
1993-07-28 |
1998-12-29 |
Pharmaderm Laboratories Ltd. |
Biphasic multilamellar lipid vesicles
|
IL107471A
(en)
*
|
1993-11-02 |
1997-09-30 |
Yissum Res Dev Co |
Pharmaceutical preparation comprising a self- emulsifying formulation and process for its production
|
US5840328A
(en)
*
|
1994-01-11 |
1998-11-24 |
The Liposome Company, Inc. |
Treatment using arachidonic acid metabolite and particulate formulations
|
AU3361595A
(en)
*
|
1994-08-08 |
1996-03-07 |
Argus Pharmaceuticals, Inc. |
Formulation and use of carotenoids in treatment of cancer
|
US5993850A
(en)
*
|
1994-09-13 |
1999-11-30 |
Skyepharma Inc. |
Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
|
WO1996033697A1
(en)
*
|
1995-04-24 |
1996-10-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Self-emulsifiable formulation producing an oil-in-water emulsion
|
US5931809A
(en)
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
IL117773A
(en)
*
|
1996-04-02 |
2000-10-31 |
Pharmos Ltd |
Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
|
US5997899A
(en)
|
1996-10-01 |
1999-12-07 |
Skyepharma Inc. |
Method for producing liposomes with increased percent of compound encapsulated
|
CA2296056A1
(en)
*
|
1997-07-10 |
1999-01-21 |
Keith Baker |
Methods for universally distributing therapeutic agents to the brain
|
US6306432B1
(en)
|
1997-09-08 |
2001-10-23 |
Chiron Corporation |
High and low load formulations of IGF-I in multivesicular liposomes
|
CN1320880C
(en)
|
1998-12-23 |
2007-06-13 |
伊迪亚股份公司 |
Improved formulation for topical non-invasive application in vivo
|
ES2173679T3
(en)
|
1999-01-27 |
2002-10-16 |
Idea Ag |
IMMUNIZATION / TRANSNASAL TRANSPORTATION WITH HIGHLY ADAPTABLE VEHICLES.
|
EP1031346B1
(en)
|
1999-01-27 |
2002-05-02 |
Idea Ag |
Noninvasive vaccination through the skin
|
MXPA02000053A
(en)
|
1999-07-05 |
2003-07-21 |
Idea Ag |
A method for the improvement of transport across adaptable semi-permeable barriers.
|
US20030068361A1
(en)
*
|
2001-10-09 |
2003-04-10 |
Rimona Margalit |
Liposome-encapsulated insulin formulations
|
US7473432B2
(en)
|
2002-10-11 |
2009-01-06 |
Idea Ag |
NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
|
US20070248541A1
(en)
*
|
2003-12-01 |
2007-10-25 |
Mitsubishi Pharma Corporation |
Liposome
|
CN103200932A
(en)
*
|
2010-06-23 |
2013-07-10 |
布莱特赛德创新有限公司 |
Lecithin carrier vesicles and methods of making the same
|
US20150182542A1
(en)
*
|
2012-02-16 |
2015-07-02 |
Brightside Innovations, Inc. |
Dietary and nutritional compositions and methods of use
|
JP6661319B2
(en)
*
|
2015-09-28 |
2020-03-11 |
小林製薬株式会社 |
Liposome
|
CN117205094A
(en)
*
|
2017-05-23 |
2023-12-12 |
大江生医股份有限公司 |
Use of emulsified liposome composition for preparing high temperature resistant liposome
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|